Kura Oncology Inc Asset Turnover Ratio (KURA), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kura Oncology Inc   (NASDAQ: KURA)
 

Kura Oncology Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Kura Oncology Inc asset turnover ratio, the ability of Kura Oncology Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.12 in the second quarter (Jun 30 2026), KURA's balance sheet remain strong.

Within sector 154 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2289 to 3158.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KURA Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -13.87 % -12.24 % -2.6 % 35.71 % 32.48 %
Y / Y Revenue Change 36.54 % 29.47 % -67.83 % - -
Asset Turnover Ratio (TTM) 0.12 0.11 0.1 0.15 0.13
KURA's Total Ranking # 3158 # 2289 # 2855 # 2369 # 0
Seq. Asset Change -9.92 % -11.62 % 13.7 % -4.84 % -8.22 %
Seq. Revenue Change 14.28 % 5.36 % -16.45 % 35.73 % 8.36 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 155
Healthcare Sector # 467
Overall Market # 3158

Asset Turnover Ratio Statistics
High Average Low
0.15 0.08 0
(Sep 30 2025)   (Mar 31 2016)




KURA Company Profile • Back to KURA Efficiency Comparisons • Compare KURA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Ionis Pharmaceuticals Inc   0.36 $ 1,169.419  Millions$ 3,238.360  Millions
Bionexus Gene Lab Corp   0.36 $ 3.127  Millions$ 8.660  Millions
Sensus Healthcare Inc   0.36 $ 18.294  Millions$ 51.035  Millions
Innovative Eyewear Inc   0.36 $ 3.412  Millions$ 9.567  Millions
Iovance Biotherapeutics inc   0.36 $ 324.969  Millions$ 914.829  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,105.000  Millions$ 40,125.250  Millions
Cardiff Lexington Corporation  0.35 $ 10.213  Millions$ 29.417  Millions
Ptc Therapeutics inc   0.35 $ 1,008.754  Millions$ 2,915.512  Millions
The Cooper Companies Inc   0.34 $ 4,236.600  Millions$ 12,486.325  Millions
Invo Fertility Inc   0.34 $ 7.531  Millions$ 22.386  Millions
Krystal Biotech Inc   0.32 $ 440.484  Millions$ 1,367.876  Millions
Pelthos Therapeutics Inc   0.32 $ 43.304  Millions$ 134.891  Millions
Volitionrx Limited  0.32 $ 2.458  Millions$ 7.672  Millions
Waters Corporation  0.31 $ 4,644.249  Millions$ 14,805.279  Millions
Opko Health Inc   0.31 $ 587.896  Millions$ 1,903.425  Millions
Pfizer Inc  0.31 $ 63,696.000  Millions$ 206,410.000  Millions
Sonida Senior Living Inc   0.31 $ 525.973  Millions$ 1,718.907  Millions
Profound Medical Corp   0.30 $ 19.086  Millions$ 63.905  Millions
Prestige Consumer Healthcare Inc   0.30 $ 1,104.957  Millions$ 3,726.846  Millions
Orchestra Biomed Holdings Inc   0.29 $ 31.976  Millions$ 109.006  Millions
Utah Medical Products Inc  0.29 $ 35.679  Millions$ 123.368  Millions
Immunitybio inc   0.29 $ 165.792  Millions$ 574.007  Millions
Zomedica Corp   0.29 $ 35.903  Millions$ 124.406  Millions
Amarin Corp Plcuk  0.29 $ 186.480  Millions$ 650.179  Millions
Orasure Technologies Inc  0.29 $ 111.978  Millions$ 391.497  Millions
Vir Biotechnology Inc   0.28 $ 303.227  Millions$ 1,065.667  Millions
Maravai Lifesciences Holdings Inc   0.28 $ 207.886  Millions$ 734.183  Millions
Atara Biotherapeutics Inc   0.28 $ 6.452  Millions$ 22.856  Millions
Assembly Biosciences Inc   0.28 $ 74.845  Millions$ 265.982  Millions
Hyperfine Inc   0.28 $ 15.425  Millions$ 55.028  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.